Detalhe da pesquisa
1.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med
; 386(5): 437-448, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045221
2.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060236
3.
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Int J Gynecol Cancer
; 31(11): 1428-1436, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610971
4.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
J Clin Oncol
; 41(35): 5400-5410, 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669480